Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 56 M43 M38 M40 M 177 M Research & development ———— — Operating income 1.19 B1.38 B1.35 B1.55 B 5.46 B Non-Operating Income, Total -52 M-89 M-85 M556 M 330 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses -59 M-76 M-79 M566 M 352 M Unusual income/expense 7 M-13 M-6 M-10 M -22 M Pretax income 1.13 B1.29 B1.26 B2.11 B 5.79 B Equity in earnings ———— — Taxes 310 M333 M207 M510 M 1.36 B Non-controlling/minority interest ———— — After tax other income/expense -718 M-719 M-760 M-740 M -2.94 B Net income before discontinued operations 824 M956 M1.06 B1.6 B 4.43 B Discontinued operations ———— — Net income 824 M956 M1.06 B1.6 B 4.43 B Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 823 M955 M1.05 B1.59 B 4.43 B Basic earnings per share (Basic EPS) 3.484.074.466.7 18.71 Diluted earnings per share (Diluted EPS) 3.464.044.416.64 18.55 Average basic shares outstanding 236 M235 M236 M237 M — Diluted shares outstanding 238 M236 M239 M239 M — EBITDA 2.28 B2.45 B2.46 B2.65 B 9.83 B EBIT 1.19 B1.38 B1.35 B1.55 B 5.46 B Cost of revenue 1.72 B1.78 B1.63 B2.26 B 7.38 B Other cost of goods sold 1.72 B1.78 B1.63 B2.26 B 7.38 B Depreciation & amortization (cash flow) 1.09 B1.07 B1.11 B1.1 B 4.37 B